Found 1 results

Sort by: Author [ Title  (Desc)] Type Year
Filters: First Letter Of Title is C  [Clear All Filters]
A B [C] D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Nyamweya NN, Kimani SN, Abuga KO. "Chewable Antacid Tablets: Are Disintegration Tests Relevant?" AAPS PharmSciTech . 2020;21:139. Abstract

A recently published FDA guidance on chewable tablets has addressed the quality attributes of this class of dosage forms. This study evaluated disintegration as a quality attribute for a number of commercially available chewable antacid tablets. Additionally, acid-neutralizing-capacity values were evaluated. A number of the products exhibited prolonged disintegration times—which were far longer than those of conventional immediate-release tablets. The mean disintegration times ranged from 6 to more than 60 min in distilled water and from 9 to over 60 min in 0.1 N HCl. The products with longer disintegration times had higher breaking force and tensile strength values. Despite the range in disintegration times, all products met the criteria for acid-neutralizing capacity. These results indicate a need for patients to be aware of the need to thoroughly chew antacid tablets upon administration. Given these considerations, disintegration testing would be a useful quality control test in evaluating these dosage forms as the implicit assumption by the manufacturer that patients will chew the product sufficiently may not be met in every case.

UoN Websites Search